N. C. Cross

Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1 (2009)

Chase, A., Schultheis, B., Kreil, S., Baxter, J., Hidalgo-Curtis, C., Jones, A., ...

Imatinib is usually a highly effective treatment for myeloproliferative neoplasms (MPNs) associated with ABL, PDGFRA or PDGFRB gene fusions; however, occasional imatinib-responsive patients have been...

Amplification refractory mutation system (ARMS), a highly sensitive and simple PCR assay for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders (2006)

Chen, Q., Lu, P., Jones, A.V., Cross, N.C., Silver, T., Wang, Y.L.

Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells.

Carapeti, M., Aguiar, R. C., Sill, H., Goldman, J. M., Cross, N. C.

Deletions and apparent transcriptional abnormalities of the FHIT gene at 3p14.2 have recently been reported in a wide variety of solid tumours. To determine whether lesions of this gene also occur in...

Rarity of microsatellite alterations in acute myeloid leukaemia.

Sill, H., Goldman, J. M., Cross, N. C.

We have analysed samples from 20 patients with acute myeloid leukaemia for microsatellite alterations by comparing constitutional DNA and DNA from leukaemic samples. Twelve microsatellites were...